China Injectable Drug Delivery Formulation Market Research Report 2018

China Injectable Drug Delivery Formulation Market Research Report 2017

1 Injectable Drug Delivery Formulation Overview

1.1 Product Overview and Scope of Injectable Drug Delivery Formulation

1.2 Classification of Injectable Drug Delivery Formulation by Product Category

1.2.1 China Injectable Drug Delivery Formulation Sales (K Pcs) Comparison by Type (2012-2022)

1.2.2 China Injectable Drug Delivery Formulation Sales (K Pcs) Market Share by Type in 2016

1.2.3 Conventional Drug Delivery Formulations

1.2.4 Novel Drug Delivery Formulations

1.2.5 Long-acting Formulations

1.3 China Injectable Drug Delivery Formulation Market by Application/End Users

1.3.1 China Injectable Drug Delivery Formulation Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)

1.3.2 Autoimmune Diseases

1.3.3 Hormonal Disorders

1.3.4 Oncology

1.3.5 Orphan Diseases

1.3.6 Others

1.4 China Injectable Drug Delivery Formulation Market by Region

1.4.1 China Injectable Drug Delivery Formulation Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Injectable Drug Delivery Formulation Status and Prospect (2012-2022)

1.4.3 East China Injectable Drug Delivery Formulation Status and Prospect (2012-2022)

1.4.4 Southwest China Injectable Drug Delivery Formulation Status and Prospect (2012-2022)

1.4.5 Northeast China Injectable Drug Delivery Formulation Status and Prospect (2012-2022)

1.4.6 North China Injectable Drug Delivery Formulation Status and Prospect (2012-2022)

1.4.7 Central China Injectable Drug Delivery Formulation Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Injectable Drug Delivery Formulation (2012-2022)

1.5.1 China Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2022)

1.5.2 China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Injectable Drug Delivery Formulation Market Competition by Players/Manufacturers

2.1 China Injectable Drug Delivery Formulation Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Injectable Drug Delivery Formulation Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Injectable Drug Delivery Formulation Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)

2.4 China Injectable Drug Delivery Formulation Market Competitive Situation and Trends

2.4.1 China Injectable Drug Delivery Formulation Market Concentration Rate

2.4.2 China Injectable Drug Delivery Formulation Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Injectable Drug Delivery Formulation Manufacturing Base Distribution, Sales Area, Product Types

3 China Injectable Drug Delivery Formulation Sales and Revenue by Region (2012-2017)

3.1 China Injectable Drug Delivery Formulation Sales (K Pcs) and Market Share by Region (2012-2017)

3.2 China Injectable Drug Delivery Formulation Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Injectable Drug Delivery Formulation Price (USD/Pcs) by Regions (2012-2017)

4 China Injectable Drug Delivery Formulation Sales and Revenue by Type/ Product Category (2012-2017)

4.1 China Injectable Drug Delivery Formulation Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)

4.2 China Injectable Drug Delivery Formulation Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2012-2017)

4.4 China Injectable Drug Delivery Formulation Sales Growth Rate (%) by Type (2012-2017)

5 China Injectable Drug Delivery Formulation Sales by Application (2012-2017)

5.1 China Injectable Drug Delivery Formulation Sales (K Pcs) and Market Share by Application (2012-2017)

5.2 China Injectable Drug Delivery Formulation Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Injectable Drug Delivery Formulation Players/Suppliers Profiles and Sales Data

6.1 Becton, Dickinson and Company (U.S.)

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 Baxter International Inc. (U.S.)

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 Gerresheimer AG (Germany)

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 Pfizer, Inc. (U.S.)

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 Schott AG (Germany)

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

6.6 Sandoz (Germany)

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.6.4 Main Business/Business Overview

6.7 Teva Pharmaceutical Industries Ltd. (Israel)

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.7.4 Main Business/Business Overview

6.8 Eli Lilly and Company (U.S.)

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Injectable Drug Delivery Formulation Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.8.4 Main Business/Business Overview

7 Injectable Drug Delivery Formulation Manufacturing Cost Analysis

7.1 Injectable Drug Delivery Formulation Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Injectable Drug Delivery Formulation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Injectable Drug Delivery Formulation Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Injectable Drug Delivery Formulation Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Injectable Drug Delivery Formulation Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)

11.2 China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Type (2017-2022)

11.3 China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Application (2017-2022)

11.4 China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Injectable Drug Delivery Formulation Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type

Table Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2016-2022)

Figure Product Picture of Injectable Drug Delivery Formulation

Table China Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Injectable Drug Delivery Formulation Sales Volume Market Share by Types in 2016

Figure Conventional Drug Delivery Formulations Product Picture

Figure Novel Drug Delivery Formulations Product Picture

Figure Long-acting Formulations Product Picture

Figure China Injectable Drug Delivery Formulation Sales (K Pcs) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Injectable Drug Delivery Formulation by Application in 2016

Figure Autoimmune Diseases Examples

Table Key Downstream Customer in Autoimmune Diseases

Figure Hormonal Disorders Examples

Table Key Downstream Customer in Hormonal Disorders

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure Orphan Diseases Examples

Table Key Downstream Customer in Orphan Diseases

Figure Others Examples

Table Key Downstream Customer in Others

Figure South China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2022)

Figure China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Injectable Drug Delivery Formulation Sales of Key Players/Manufacturers (2012-2017)

Table China Injectable Drug Delivery Formulation Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Injectable Drug Delivery Formulation Sales Share (%) by Players/Manufacturers

Figure 2017 China Injectable Drug Delivery Formulation Sales Share (%) by Players/Manufacturers

Table China Injectable Drug Delivery Formulation Revenue by Players/Manufacturers (2012-2017)

Table China Injectable Drug Delivery Formulation Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Injectable Drug Delivery Formulation Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Injectable Drug Delivery Formulation Revenue Market Share (%) by Players/Manufacturers

Table China Market Injectable Drug Delivery Formulation Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Injectable Drug Delivery Formulation Average Price of Key Players/Manufacturers in 2016

Figure China Injectable Drug Delivery Formulation Market Share of Top 3 Players/Manufacturers

Figure China Injectable Drug Delivery Formulation Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Injectable Drug Delivery Formulation Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Injectable Drug Delivery Formulation Product Category

Table China Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)

Table China Injectable Drug Delivery Formulation Sales Share (%) by Regions (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Share (%) by Regions (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Market Share (%) by Regions in 2016

Table China Injectable Drug Delivery Formulation Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Injectable Drug Delivery Formulation Revenue Market Share (%) by Regions (2012-2017)

Figure China Injectable Drug Delivery Formulation Revenue Market Share (%) by Regions (2012-2017)

Figure China Injectable Drug Delivery Formulation Revenue Market Share (%) by Regions in 2016

Table China Injectable Drug Delivery Formulation Price (USD/Pcs) by Regions (2012-2017)

Table China Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2012-2017)

Table China Injectable Drug Delivery Formulation Sales Share (%) by Type (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Share (%) by Type (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Market Share (%) by Type in 2016

Table China Injectable Drug Delivery Formulation Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Injectable Drug Delivery Formulation Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Injectable Drug Delivery Formulation by Type (2012-2017)

Figure Revenue Market Share of Injectable Drug Delivery Formulation by Type in 2016

Table China Injectable Drug Delivery Formulation Price (USD/Pcs) by Types (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Growth Rate (%) by Type (2012-2017)

Table China Injectable Drug Delivery Formulation Sales (K Pcs) by Applications (2012-2017)

Table China Injectable Drug Delivery Formulation Sales Market Share (%) by Applications (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Market Share (%) by Application (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Market Share (%) by Application in 2016

Table China Injectable Drug Delivery Formulation Sales Growth Rate (%) by Application (2012-2017)

Figure China Injectable Drug Delivery Formulation Sales Growth Rate (%) by Application (2012-2017)

Table Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Basic Information List

Table Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Basic Information List

Table Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Basic Information List

Table Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Basic Information List

Table Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Schott AG (Germany) Injectable Drug Delivery Formulation Basic Information List

Table Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Schott AG (Germany) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Schott AG (Germany) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Sandoz (Germany) Injectable Drug Delivery Formulation Basic Information List

Table Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Sandoz (Germany) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Sandoz (Germany) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Basic Information List

Table Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Basic Information List

Table Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in China (2012-2017)

Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in China (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Injectable Drug Delivery Formulation

Figure Manufacturing Process Analysis of Injectable Drug Delivery Formulation

Figure Injectable Drug Delivery Formulation Industrial Chain Analysis

Table Raw Materials Sources of Injectable Drug Delivery Formulation Major Players/Manufacturers in 2016

Table Major Buyers of Injectable Drug Delivery Formulation

Table Distributors/Traders List

Figure China Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)

Figure China Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Injectable Drug Delivery Formulation Price (USD/Pcs) Trend Forecast (2017-2022)

Table China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Type in 2022

Table China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Application (2017-2022)

Figure China Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Application in 2022

Table China Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Regions (2017-2022)

Table China Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions (2017-2022)

Figure China Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions (2017-2022)

Figure China Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources